91-105 of 564
Examining the Correlation Between HIV & Neurocognitive Disorders
NeuroFrontiersExamining the Correlation Between HIV & Neurocognitive Disorders
NIH Study Identifies Cause for Long COVID Neurological Symptoms
NeuroFrontiersNIH Study Identifies Cause for Long COVID Neurological Symptoms
Investigating CAR T-Cell Therapy for HIV Treatment
Clinician's RoundtableInvestigating CAR T-Cell Therapy for HIV Treatment
mAB Treatment for COVID-19 Does Not Impact HDP Rates
Advances in Women's HealthmAB Treatment for COVID-19 Does Not Impact HDP Rates
Stopping Stigma Surrounding Monkeypox with Provider Education
NeuroFrontiersStopping Stigma Surrounding Monkeypox with Provider Education
How Different Types of Influenza Vaccines Are Made
VacciNationHow Different Types of Influenza Vaccines Are Made
- advertisement
The Aging HIV Population: Combatting Challenges & Addressing Stigma
Clinician's RoundtableThe Aging HIV Population: Combatting Challenges & Addressing Stigma
The Role of Antivirals in COVID-19 Rebound Infections
COVID-19: On The FrontlinesThe Role of Antivirals in COVID-19 Rebound Infections
Key Diagnostic Barriers & Guideline Updates for Pneumonia
Deep Breaths: Updates from CHESTKey Diagnostic Barriers & Guideline Updates for Pneumonia
Tackling the Tripledemic: A Look at Combatting COVID-19, RSV, & the Flu
COVID-19: On The FrontlinesTackling the Tripledemic: A Look at Combatting COVID-19, RSV, & the Flu
A Debate on Dosing Considerations: Perspectives on Antimicrobials
IDSA Action CenterA Debate on Dosing Considerations: Perspectives on Antimicrobials
Looking Back to Look Ahead: Lessons Learned from the Monkeypox Outbreak
IDSA Action CenterLooking Back to Look Ahead: Lessons Learned from the Monkeypox Outbreak
- advertisement
Can Generic Drugs Be Repurposed for COVID-19 Treatment?
Diabetes DiscourseCan Generic Drugs Be Repurposed for COVID-19 Treatment?
Updates in Vaccination: Insights from IDWeek
IDSA Action CenterUpdates in Vaccination: Insights from IDWeek
Key COVID-19 Considerations: Highlights from Poster Sessions at IDWeek
IDSA Action CenterKey COVID-19 Considerations: Highlights from Poster Sessions at IDWeek
